Logo

Applied Biosystems Sells 50 Sequencers to DeCode

Nov 03, 2000

NEW YORK, Nov 3 – Applied Biosystems and DeCode Genetics officially announced Friday that DeCode has purchased 50 ABI Prism 3700 DNA Analyzers as part of its efforts to genotype the Icelandic population.

GenomeWeb first reported this deal in September.

Terms of the transaction were not disclosed but t he price for the 3700 sequencer is $250,000, not including any discounts that big buyers may receive.  

Over the past two years, Applied Biosystems has sold about 2,000 of the 3700 units.

DeCode said the 3700s would help it to increase its average genotyping throughput nearly fivefold to about 12 million genotypes a month.  

In addition to its genotyping efforts, DeCode is also planning to begin commercializing its informatics tools in the near future. The company expects to announce a deal to provide its software to an unnamed customer in the next couple of months.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.